Month: August 2022

MELBOURNE, Australia, Aug. 14, 2022 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT; NASDAQ: OPT) (Opthea), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, is pleased to confirm it has received binding commitments for a successful two-tranche placement (Placement) of new fully paid ordinary shares (New Shares) to institutional investors to raise approximately US$90 million1 (A$128.57 million) at a price of A$1.15 per New Share (Placement Price), which represents a 12.6% discount to the 10-day Volume-Weighted Average Price (VWAP) as of 10 August 2022. As noted in Opthea’s announcement today, Opthea has entered into a non-dilutive financing arrangement for up to US$170 million with Carlyle and Abingworth, in collaboration with their recently formed development...

Carlyle and its life sciences franchise Abingworth, working with their recently formed development company Launch Therapeutics (Launch Tx), to provide non-dilutive financing of up to US$170M, consisting of a US$120M commitment and an option to increase funding by a further US$50M If OPT-302 is approved in a major market, Carlyle and Abingworth will be eligible to receive fixed success payments and variable success payments of 7% on annual net sales, which terminate after reaching four times the funded amount   In addition, Opthea has received commitments for US$90M1 (A$128.57M) via a private institutional equity placement for new shares and launched an A$5M Share Purchase Plan (SPP) Opthea is expected to be fully funded through pivotal Phase 3 topline data and pre-commercial activities and retains full worldwide commercial rights to OPT-302 Financing...

Figure 1 Olaroz and Cauchari showing Maria Victoria tenementBRISBANE, Australia, Aug. 14, 2022 (GLOBE NEWSWIRE) — Allkem Limited (ASX|TSX: “Allkem,” the Company”) advises it has entered into a binding and conditional Heads of Agreement (“HOA”) to transfer Borax Argentina S.A (“Borax”) to Minera Santa Rita S.R.L (“MSR”) and to acquire the María Victoria lithium tenement from MSR in return (the “Proposed Transaction”). HIGHLIGHTSAllkem will acquire 100% of the strategic lithium tenement of María Victoria located north of the Olaroz Lithium Facility (“María Victoria Tenement”) and in exchange transfer to MSR all of the shares in the Borax holding companies and US$14 million cash1 for employee and rehabilitation liabilities Conditions precedent to completion of the Proposed Transaction include transfer of certain lithium tenements...

AUSTIN, Texas, Aug. 13, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, yesterday presented positive data from two ongoing clinical trials of its lead investigational drug, Rhenium-186 Nanoliposome (186RNL), in the treatment of recurrent glioblastoma (GBM) and leptomeningeal metastases (LM) at the 2022 Annual Conference on CNS Clinical Trials and Brain Metastases. The conference is co-sponsored by the Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO) and is being held August 12-13, 2022 in Toronto, Canada. The oral presentation, titled Safety and Feasibility of Rhenium-186 Nanoliposome (186RNL) in Leptomeningeal Metastases Phase 1/2a...

VANCOUVER, British Columbia, Aug. 12, 2022 (GLOBE NEWSWIRE) —  (TSXV: PTF) Pender Growth Fund Inc. (the “Company” or “PTF”) is pleased to report that long time holding D-Wave Systems Inc. (“D-Wave”) has recently announced the completion of its previously announced intention to list publicly via a business combination with DPCM Capital, Inc. (“DPCM Capital”), a publicly traded special purpose acquisition company. On August 8, 2022, D-Wave began trading on the New York Stock Exchange under the symbol QBTS. PTF holds 199,411 shares of D-Wave directly and owns approximately 98% of Pender Private Investments Inc. which holds 548,427 shares of D-Wave. The merger enables public investors to invest in a quantum computing company and enhances D-Wave’s position as a center of Canadian quantum computing innovation and technology. D-Wave is...

Operations Continue in Ordinary Course during Voting Process SAULT STE. MARIE, Ontario, Aug. 12, 2022 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or the “Company”) announced today that United Steelworkers Local 2251 (“2251” or the “Union”) have agreed to take the Company’s last offer to a vote by employees in the affected bargaining unit. Operations will continue in the ordinary course during the voting process, and the Union has agreed to provide advance notice to the Company to allow for a safe and orderly shutdown of operations in the event the Union instructs employees to go on strike. Algoma President and Chief Executive Officer Michael Garcia commented. “We respect the collective bargaining process and are pleased that our employees will have their say on a matter of such critical importance...

New York, NY, Aug. 12, 2022 (GLOBE NEWSWIRE) — Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”), a special purpose acquisition company, announced today the termination of its previously announced agreement and plan of merger (the “Merger Agreement”) with Calidi Biotherapeutics, Inc. (“Calidi”). Although Edoc and Calidi may continue to discuss the possibility of engaging in a business combination, there can be no assurance that those discussions will result in a transaction between Edoc and Calidi proceeding on the current terms of the Business Combination, if at all. As a result of the termination of the Merger Agreement, Edoc intends to promptly begin simultaneously evaluating other possible business combination targets.  About Edoc Acquisition Corp. Edoc Acquisition Corp. is a blank check company organized...